Comparison of efficacy and tolerability of somatostatin analogs and other therapies for acromegaly

ISSN： 0969-711X

Source： Endocrine Journal, Vol.20, Iss.3, 2003-04, pp. : 299-305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Somatostatin analogs in medical treatment of acromegaly

By Racine Michael Barkan Ariel

Endocrine Journal, Vol. 20, Iss. 3, 2003-04 ,pp. : 271-278

Humana Press, Inc

Access to resources Recommend Favorite

Somatostatin analogs as primary medical therapy for acromegaly

By Danoff Ann Kleinberg David

Endocrine Journal, Vol. 20, Iss. 3, 2003-04 ,pp. : 291-297

Humana Press, Inc

Access to resources Recommend Favorite

Primary Therapy for Acromegaly with Somatostatin Analogs and a Discussion of Novel Peptide Analogs

By Kleinberg David

Reviews in Endocrine and Metabolic Disorders, Vol. 6, Iss. 1, 2005-01 ,pp. : 29-37

Springer Publishing Company

Access to resources Recommend Favorite

Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review

By Fleseriu Maria

Pituitary, Vol. 14, Iss. 2, 2011-06 ,pp. : 184-193

Springer Publishing Company

Access to resources Recommend Favorite

Somatostatin Analogs as Radiodiagnostic Tools

By Herder Wouter Lamberts Steven

Reviews in Endocrine and Metabolic Disorders, Vol. 6, Iss. 1, 2005-01 ,pp. : 23-27

Springer Publishing Company

Access to resources Recommend Favorite